Home › NDC Lookup › RxCUI directory › RxCUI 646333

Capsaicin 1 MG/ML Topical Cream — RxCUI 646333

RxNorm drug concept · Semantic clinical drug
RxCUI 646333 Semantic clinical drug · SCD ● Current RxNorm concept 23 FDA products 23 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI646333
Official nameCapsaicin 1 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascapsaicin 0.1 % Topical Cream
FDA products mapped23
Package NDCs mapped23
Reported Medicaid activity (SDUD)12,527 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Capsaicin Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It gives temporary relief of minor aches and pains in muscles and joints. That includes pain from simple backache, arthritis, strains, bruises and sprains.
  • Clean and dry the area, then put the patch on intact skin right after taking it out of the pouch. Adults can use up to 3 patches a day, one at a time, and each should come off with...
  • You may notice a burning feeling, and warm water, sweat or heat can make it stronger. Avoid use within an hour before or after a shower, bath, sauna or hard exercise. Never use it...
  • Keep it off your face, eyes, other mucous membranes, and any wounds or irritated, broken, sunburned or chapped skin. If it gets in your eyes, rinse continually with cool water and...
📖 Read our full Capsaicin Topical guide →

🕸️ Concept Web — How Capsaicin 1 MG/ML Topical Cream Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Capsaicin 1 MG/ML Topical Cream RxCUI 646333

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Capsaicin 1992
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Capzasin-HP 794241
    • Zostrix 94650
  3. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Capsaicin Topical Cream 377632
    • Capsaicin Topical Product 1155739
    • Capsaicin Topical Cream [Capzasin-HP] 794243
    • Capsaicin Topical Cream [Zostrix] 362176
    • Capzasin-HP Topical Product 1173673
    • Zostrix Topical Product 1186320
    • Topical Cream 316982
    • Topical Product 1151122
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Capsaicin 1 MG/ML 636773
    • Capsaicin 1 MG/ML Topical Cream [Capzasin-HP] 794244
    • Capsaicin 1 MG/ML Topical Cream [Zostrix] 804752
    • Capsaicin 1 MG/ML [Capzasin-HP] 794242
    • Capsaicin 1 MG/ML [Zostrix] 1926233

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Capsaicin 1 MG/ML SCDC · 636773
  • Capsaicin Topical Cream SCDF · 377632
  • Capsaicin Topical Product SCDG · 1155739

Brand-Name Concepts

  • Capsaicin 1 MG/ML Topical Cream [Capzasin-HP] SBD · 794244
  • Capsaicin 1 MG/ML Topical Cream [Zostrix] SBD · 804752
  • Capsaicin 1 MG/ML [Capzasin-HP] SBDC · 794242
  • Capsaicin 1 MG/ML [Zostrix] SBDC · 1926233
  • Capsaicin Topical Cream [Capzasin-HP] SBDF · 794243
  • Capsaicin Topical Cream [Zostrix] SBDF · 362176
  • Capzasin-HP Topical Product SBDG · 1173673
  • Zostrix Topical Product SBDG · 1186320
  • Capzasin-HP BN · 794241
  • Zostrix BN · 94650

📦 FDA Products & Package NDCs

23 products · 23 package NDCs
23 package NDCs map to RxCUI 646333 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00363-0837-01 1 TUBE in 1 CARTON (0363-0837-01) / 42.5 g in 1 TUBE Walgreens Arthritis Pain Relief Capsaicin Analgesic Walgreen Company 2010-05-03
00363-6263-07 1 APPLICATOR in 1 CARTON (0363-6263-07) / 85 g in 1 APPLICA... Heat Pain Relief Walgreen Company 2025-02-28
00536-1264-56 1 TUBE in 1 BOX (0536-1264-56) / 42.5 g in 1 TUBE Rugby Capsaicin Cream Rugby Laboratories 2020-02-17
24286-1559-02 1 TUBE in 1 BOX (24286-1559-2) / 68 g in 1 TUBE EARTHS CARE ARTHRITIS DLC Laboratories, Inc. 2013-09-25
41167-7514-02 1 TUBE in 1 CARTON (41167-7514-2) / 42.5 g in 1 TUBE Capzasin HP Arthritis Pain Relief Chattem, Inc. 1998-12-01
50268-0197-56 1 TUBE in 1 CARTON (50268-197-56) / 56.6 g in 1 TUBE Capsaicin AvPAK 2022-12-08
50268-0198-42 1 TUBE in 1 CARTON (50268-198-42) / 42.5 g in 1 TUBE Capsaicin AvPAK 2022-12-08
50488-1060-06 60 g in 1 BOTTLE (50488-1060-6) Capsaicin 0.1 Percent Alexso, Inc 2020-02-01
59088-0242-08 120 g in 1 BOTTLE, PUMP (59088-242-08) Capsaicin 0.1% Cream Puretek Corporation 2026-04-03
59779-0381-42 1 TUBE in 1 CARTON (59779-381-42) / 42 g in 1 TUBE CVS CAPSAICIN CVS PHARMACY 2014-10-13
69375-0006-60 1 TUBE in 1 CARTON (69375-006-60) / 56.6 g in 1 TUBE Capsaicin HP Arthritis Pain Relief Nationwide Pharmaceutical LLC 2023-08-21
69396-0103-02 1 TUBE in 1 BOX (69396-103-02) / 60 g in 1 TUBE Capsaicin Cream Trifecta Pharmaceuticals USA LLC 2022-05-14
70000-0549-01 1 TUBE in 1 BOX (70000-0549-1) / 42.5 g in 1 TUBE Leader Capsaicin Pain Relief Cream Cardinal Health 110 dba LEADER 2020-05-11
72847-0316-20 1 TUBE in 1 CARTON (72847-316-20) / 56.6 g in 1 TUBE CAPZIX Toprail Chp Llc. 2019-07-19
73141-0558-02 1 TUBE in 1 BOX (73141-558-02) / 60 g in 1 TUBE Capsaicin Cream A2A Integrated Pharmaceuticals, LLC 2024-03-25
76420-0753-42 1 TUBE in 1 CARTON (76420-753-42) / 42.5 g in 1 TUBE Capsaicin Asclemed USA, Inc. 2024-06-20
78983-0102-05 148 g in 1 TUBE (78983-102-05) Toast Screamin Hot IDEAZ, LLC 2025-06-01
81533-0200-15 1 TUBE in 1 BOX (81533-200-15) / 42.5 g in 1 TUBE Capsaicin Cream Noble OTC LLC 2022-07-14
84066-0108-01 100 g in 1 TUBE (84066-108-01) NeroCare Capsaicin Neuropathy Relief Cream Guangzhou Tata Biotechnology Co., Ltd. 2026-04-03
87147-0003-01 114 g in 1 JAR (87147-003-01) Dr. Luke Capsaicin Cream Extra Strength DANOUS LAND FLOOW LLC 2025-10-13
87352-0001-01 120 g in 1 CARTON (87352-001-01) Easment advanced absorption cream Easment LLC 2026-02-18
87352-0005-01 120 g in 1 CARTON (87352-005-01) Easment 0.1% Capsaicin cream for sensitive skin Easment LLC 2026-06-30
87773-0001-01 114 g in 1 BOTTLE (87773-001-01) HIGH POTENCY PAIN RELIEF Xiamen Weisiqi Technology Co., Ltd. 2026-06-14
Observed labelers: AvPAK (2) · Easment LLC (2) · Walgreen Company (2) · A2A Integrated Pharmaceuticals, LLC (1) · Alexso, Inc (1) · Asclemed USA, Inc. (1) · +14 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.